Iridex (IRIX) Capital Expenditures Growth (5y) (2016 - 2026)
Iridex (IRIX) Capital Expenditures Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn |
| 10 | Iridex | 15.20 Mn | 10.60 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 31.32% |
| Sep 27, 2025 | 31.16% |
| Jun 28, 2025 | -17.90% |
| Mar 29, 2025 | -54.23% |
| Dec 28, 2024 | 115.37% |
| Sep 28, 2024 | -26.03% |
| Jun 29, 2024 | 29.67% |
| Mar 30, 2024 | 18.47% |
| Dec 30, 2023 | -11.43% |
| Sep 30, 2023 | 31.33% |
| Jul 1, 2023 | 39.77% |
| Apr 1, 2023 | 9.75% |
| Dec 31, 2022 | 2.41% |
| Oct 1, 2022 | 28.57% |
| Jul 2, 2022 | 29.35% |
| Apr 2, 2022 | -40.24% |
| Jan 1, 2022 | -11.33% |
| Apr 3, 2021 | -21.02% |
| Mar 28, 2020 | 0.00% |
| Sep 28, 2019 | 0.00% |